Search Results - "Tsirigotis, P"

Relapse of AML after hematopoietic stem cell transplantation: methods of monitoring and preventive strategies. A review from the ALWP of the EBMT by Tsirigotis, P, Byrne, M, Schmid, C, Baron, F, Ciceri, F, Esteve, J, Gorin, N C, Giebel, S, Mohty, M, Savani, B N, Nagler, A

“…Allogeneic hematopoietic stem cell transplantation (allo-SCT) remains the therapeutic method with the most potent anti-leukemic activity mediated by the graft…”
Get full text

Incidence and risk factors for moderate-to-severe veno-occlusive disease of the liver after allogeneic stem cell transplantation using a reduced intensity conditioning regimen by Tsirigotis, P D, Resnick, I B, Avni, B, Grisariu, S, Stepensky, P, Or, R, Shapira, M Y

“…The incidence and outcome of moderate-to-severe veno-occlusive (VOD) disease was analyzed in 271 consecutive patients with hematological malignancies who…”
Get full text

Dose individualization of intravenous busulfan in pediatric patients undergoing bone marrow transplantation: impact and in vitro evaluation of infusion lag-time by Neroutsos, E, Athanasiadou, I, Paisiou, A, Zisaki, K, Goussetis, E, Archontaki, H, Tsirigotis, P, Kitra, M, Grafakos, S, Spyridonidis, A, Dokoumetzidis, A, Valsami, G

“…Abstract Objectives To apply therapeutic drug monitoring and dose-individualization of intravenous Busulfan to paediatric patients and evaluate the impact of…”
Get full text

Brentuximab vedotin in combination with or without donor lymphocyte infusion for patients with Hodgkin lymphoma after allogeneic stem cell transplantation by Tsirigotis, P, Danylesko, I, Gkirkas, K, Shem-Tov, N, Yerushalmi, R, Stamouli, M, Avigdor, A, Spyridonidis, A, Gauthier, J, Goldstein, G, Apostolidis, J, Mohty, M, Shimoni, A, Nagler, A

“…In our study, we evaluated the safety and efficacy of Brentuximab vedotin (BV) with or without the addition of donor lymphocyte infusion (DLI) after allogeneic…”
Get full text

Low-dose alemtuzumab for GvHD prevention followed by prophylactic donor lymphocyte infusions in high-risk leukemia by Tsirigotis, P, Liga, M, Gkirkas, K, Stamouli, M, Triantafyllou, E, Marangos, M, Pessach, I, Sarantopoulos, A, Spyridis, N, Spyridonidis, A

“…We analyzed the use of low-dose alemtuzumab in a cohort of 158 consecutive patients who underwent allogeneic PBSC transplantation. Patients with high-risk…”
Get full text

Treatment of Experimental Candida Sepsis with a Janus Kinase Inhibitor Controls Inflammation and Prolongs Survival by Tsirigotis, P, Papanikolaou, N, Elefanti, A, Konstantinou, P, Gkirkas, K, Rontogianni, D, Siafakas, N, Karakitsos, P, Roilides, E, Dimitriadis, G, Zerva, L, Meletiadis, J

“…Janus kinases (JAK) are intracellular tyrosine kinases that transduce cytokine-mediated signals to the nucleus, promoting gene expression. Cytokines play a…”
Get full text

RITUXIMAB‐DOSE‐ADJUSTED EPOCH (R‐DA‐EPOCH) IN PRIMARY MEDIASTINAL LARGE B‐CELL LYMPHOMA (PMLBCL): REAL‐LIFE EXPERIENCE ON 190 PATIENTS FROM 3 MEDITERRANEAN COUNTRIES by Vassilakopoulos, T., Ferhanoglu, B., Horowitz, N., Mellios, Z., Kaynar, L., Zektser, M., Symeonidis, A., Piperidou, A., Kalpadakis, C., Akay, O. M., Atalar, A. C., Katodritou, E., Leonidopoulou, T., Papageorgiou, S., Tadmor, T., Gutwein, O., Karakatsanis, S., Ganzel, C., Karianakis, G., Isenberg, G., Gainaru, G., Vrakidou, E., Palassopoulou, M., Ozgur, M., Siakantaris, M., Paydas, S., Tsirigotis, P., Tsirogianni, M., Hatzimichael, E., Tuglular, T., Chatzidimitriou, C., Megalakaki, E., Kanellias, N., Zikos, P., Koumarianou, A., Gafter‐Gvili, A., Angelopoulou, M., Karmiris, T., Gurion, R.

Get full text

Specific abnormalities versus number of abnormalities and cytogenetic scoring systems for outcome prediction after allogeneic hematopoietic SCT for myelodysplastic syndromes by Kelaidi, C, Tzannou, I, Baltadakis, I, Batsis, I, Mallouri, D, Spyridonidis, A, Gigantes, S, Tsirigotis, P, Apostolidis, I, Athanasiadou, A, Manola, K, Anagnostopoulos, A, Harhalakis, N, Sakellari, I, Karakasis, D

“…Newer cytogenetic scoring systems for myelodysplastic syndromes (MDSs), like cytogenetic stratification of the revised international prognostic scoring system…”
Get full text

P1230: PET/CT IMAGING FOR RESPONSE ASSESSMENT AND TREATMENT GUIDANCE AFTER RITUXIMAB‐DOSE‐ADJUSTED‐EPOCH(R‐DA‐EPOCH) IN PRIMARY MEDIASTINAL LARGE B‐CELL LYMPHOMA (PMLBCL):THE GREEK EXPERIENCE ON 107 PATIENTS by Vassilakopoulos, T., Piperidou, A., Mellios, Z., Verigou, E., Kalpadakis, C., Katodritou, E., Papageorgiou, S., Chatzidimitriou, C., Giatra, C., Leonidopoulou, T., Xanthopoulos, V., Karakatsanis, S., Gainaru, G., Vrakidou, E., Koumarianou, A., Hatzimichael, E., Verrou, E., Tsirogianni, M., Drandakis, I., Lefaki, M. A., Liaskas, A., Kopsaftopoulou, A., Lampropoulou, P., Kanellias, N., Zikos, P., Liapi, D., Karianakis, G., Grentzelias, D., Papadaki, E., Siakantaris, M., Tsirigotis, P., Panitsas, F., Plata, E., Bakiri, M., Datseris, I., Chatziioannou, S., Prassopoulos, V., Skoura, E., Angelopoulou, M., Symeonidis, A., Karmiris, T., Rontogianni, P.

Get full text

P1229: RITUXIMAB‐DOSE‐ADJUSTED EPOCH (R‐DA‐EPOCH) IN PRIMARY MEDIASTINAL LARGE B‐CELL LYMPHOMA (PMLBCL): REAL‐LIFE EXPERIENCE ON 225 PATIENTS FROM 4 COUNTRIES by Vassilakopoulos, T., Ferhanoglu, B., Horowitz, N. A., Apostolidis, J., Mellios, Z., Kaynar, L., Zektser, M., Symeonidis, A., Piperidou, A., Kalpadaki, C., Akay, O. M., Atalar, S. C., Sayyed, A., Katodritou, E., Leonidopoulou, T., Papageorgiou, S., Tadmor, T., Gutwein, O., Karakatsanis, S., Ganzel, C., Karianakis, G., Isenberg, G., Gainaru, G., Vrakidou, E., Palassopoulou, M., Ozgur, M., Siakantaris, M., Paydas, S., Tsirigotis, P., Tsirogianni, M., Hatzimichael, E., Tuglular, T. F., Chatzidimitriou, C., Liaskas, A., Lefaki, M. A., Kanellias, N., Zikos, P., Koumarianou, A., Gafter‐Gvili, A., Angelopoulou, M., Karmiris, T., Gurion, R.

Get full text

The Burden of Myelofibrosis In Greece by Kousoulakou, H, Symeonidis, A, Kyriakou, D, Sotiropoulos, D, Gigantes, S, Delimbasi, S, Tsirigotis, P, Hatzikou, M, Geitona, M

Get full text

Peliosis Hepatis following treatment with androgen-steroids in patients with bone marrow failure syndromes by Tsirigotis, P, Sella, T, Shapira, M.Y, Bitan, M, Bloom, A, Kiselgoff, D, Levin, M, Libster, D, Hai, A. Abdul, Gesundheit, B, Or, R, Slavin, S, Resnick, I

“…Department of Bone Marrow Transplantation and Cancer Immunotherapy; Department of Radiology, Department of Haematology; Hadassah, Hebrew University Medical…”
Get full text

The number of infused CD34+ cells does not influence the incidence of GVHD or the outcome of allogeneic PBSC transplantation, using reduced-intensity conditioning and antithymocyte globulin by Tsirigotis, P, Shapira, M Y, Or, R, Bitan, M, Samuel, S, Gesundheit, B, Ackerstein, A, Abdul-Hai, A, Slavin, S, Resnick, I B

“…The influence of graft composition on the outcome of reduced-intensity (RIC) allogeneic PBSC transplantation (allo-PBSC) remains controversial. In this study,…”
Get full text

Extracorporeal photopheresis in combination with bexarotene in the treatment of mycosis fungoides and Sézary syndrome by Tsirigotis, P., Pappa, V., Papageorgiou, S., Kapsimali, V., Giannopoulou, V., Kaitsa, I., Girkas, K., Papageorgiou, E., Stavrianeas, N., Economopoulos, T., Dervenoulas, J.

Get full text

Alefacept treatment for refractory chronic extensive GVHD by Shapira, M Y, Abdul-Hai, A, Resnick, I B, Bitan, M, Tsirigotis, P, Aker, M, Gesundheit, B, Slavin, S, Or, R

“…Alefacept (Amevive) is an immunosuppressive dimeric fusion protein that is used for psoriasis control. We recently showed its effect in acute…”
Get full text

Allogeneic hematopoietic stem cell transplantation in the elderly by Shapira, Michael Y, Tsirigotis, P, Resnick, I.B, Or, R, Abdul-Hai, A, Slavin, S

“…Abstract The development of reduced intensity or non-myeloablative conditioning (NST) in preparation for allogeneic stem cell transplantation (SCT)…”
Get full text

Keratinocyte growth factor is effective in the prevention of intestinal mucositis in patients with hematological malignancies treated with high-dose chemotherapy and autologous hematopoietic SCT: a video-capsule endoscopy study by Tsirigotis, P, Triantafyllou, K, Girkas, K, Giannopoulou, V, Ioannidou, E, Chondropoulos, S, Kalli, T, Papaxoinis, G, Pappa, V, Papageorgiou, E, Economopoulos, T, Ladas, S D, Dervenoulas, J

“…Oral and/or intestinal mucositis is a severe complication of hematopoietic SCT. Keratinocyte growth factor (KGF) has proven activity in the prevention of oral…”
Get full text

Treatment of post-hematopoietic stem cell transplantation hemorrhagic cystitis with intravesicular sodium hyaluronate by MIODOSKY, M, ABDUL-HAI, A, SLAVIN, S, SHAPIRA, M. Y, TSIRIGOTIS, P, OR, R, BITAN, M, RESNICK, I. B, GESUNDHEIT, B, ZILBERMAN, I, IOFFE, L, LEUBOVIC, A

“…Hemorrhagic cystitis (HC) is a well-known complication of HSCT. Its overall incidence has been reported to vary from 7-68%. The spectrum of clinical…”
Get full text

108 Evaluation of Greek Haematological Patients' Hope During the Phase of Hematopoietic Cell Transplantation – a Pilot Study by Tsaroucha, S, Papadatou, D, Tsirigotis, P, Katsaragakis, S, Patiraki, E

Get full text

P-213 Impact of individual cytogenetic abnormalities, IPSS-R karyotype and monosomal karyotype on outcomes after allogeneic HCT for MDS/sAML by Kelaidi, C, Sakellari, I, Tzannou, I, Liga, M, Spyridonidis, A, Tsirigotis, P, Papaioannou, G, Mallouri, D, Batsis, I, Karakasis, D, Baltadakis, I, Harhalakis, N, Athanasiadou, A, Anagnostopoulos, A

Get full text